Literature DB >> 6724216

Role of aliesterase in organophosphate poisoning.

J G Clement.   

Abstract

Various doses of CBDP (2-(2- methylphenoxy )-4H-1,3,2- benzodioxaphosphorin -2-oxide), a metabolite of tri-o-cresyl phosphate, increased dramatically the acute toxicity of soman ( pinacolyl methylphosphonofluoridate ) in mice. CBDP (5 mg/kg; iv) reduced the soman LD50 value from 136 micrograms/kg in control to 6.95 micrograms/kg. The potentiation of soman toxicity following CBDP pretreatment appeared to be due primarily to inhibition of plasma aliesterase activity. Inhibition of liver aliesterase was not of primary importance in the potentiation of soman toxicity following CBDP pretreatment. In addition pretreatment with ISO-OMPA ( tetraisopropyl pyrophosphoramide ), a selective inhibitor of pseudocholinesterase, had no effect on the acute toxicity of soman. Similarly pretreatment of mice with pyridostigmine, a quaternary carbamate anticholinesterase which does not inhibit aliesterase , resulted in marked inhibition of diaphragm, plasma, and brain acetylcholinesterase had no effect on the acute toxicity of soman. Plasma aliesterase may be a depot for soman poisoning. The acute toxicity of soman by the ip, sc, and iv routes of administration was reduced following pretreatment of mice with phenobarbital (100 mg/kg) for 4 days. The reduced toxicity of soman following phenobarbital pretreatment was due to induction of liver aliesterase activity which subsequently resulted in an increase in plasma aliesterase activity. Thus more soman was probably bound to plasma aliesterase activity resulting in a reduction in acute toxicity of soman. Conversely pretreatment of mice with pentobarbital (70 mg/kg; ip) increased the toxicity of soman. This was probably the result of inhibition of plasma aliesterase by pentobarbital pretreatment combined with the central respiratory depression following pentobarbital administration. Following pentobarbital pretreatment soman inhibition of brain acetylcholinesterase was increased suggesting that plasma aliesterase inhibition alters the distribution of free soman in vivo. In summary, in mice plasma aliesterase appears to be an extremely important detoxification route for soman in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724216     DOI: 10.1016/0272-0590(84)90141-6

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  10 in total

1.  Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).

Authors:  J G Clement; N Erhardt
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Survivors of soman poisoning: recovery of the soman LD50 to control value in the presence of extensive acetylcholinesterase inhibition.

Authors:  J G Clement
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

3.  Dose-related gene expression changes in forebrain following acute, low-level chlorpyrifos exposure in neonatal rats.

Authors:  Anamika Ray; Jing Liu; Patricia Ayoubi; Carey Pope
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-05       Impact factor: 4.219

4.  Characterization of carboxylesterase in skin mucus of Cirrhinus mrigala and its assessment as biomarker of organophosphate exposure.

Authors:  Ashwini Kumar Nigam; Usha Kumari; Swati Mittal; Ajay Kumar Mittal
Journal:  Fish Physiol Biochem       Date:  2013-10-05       Impact factor: 2.794

5.  Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases.

Authors:  Z Grubic; D Sket; M Brzin
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 6.  Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.

Authors:  Biljana Antonijevic; Milos P Stojiljkovic
Journal:  Clin Med Res       Date:  2007-03

7.  iso-OMPA-induced potentiation of soman toxicity in rat.

Authors:  R C Gupta; W D Dettbarn
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

8.  HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases.

Authors:  P Eyer; I Hagedorn; R Klimmek; P Lippstreu; M Löffler; H Oldiges; U Spöhrer; I Steidl; L Szinicz; F Worek
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

9.  In vitro age-related differences in rats to organophosphates.

Authors:  Edward C Meek; Russell L Carr; Janice E Chambers
Journal:  Toxicol In Vitro       Date:  2021-01-23       Impact factor: 3.500

10.  Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.

Authors:  J M Gearhart; G W Jepson; H J Clewell; M E Andersen; R B Conolly
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.